EOS Imaging (Formerly Known as biospace med) Reports First Half 2013 Results

Today, EOS imaging (Paris:EOSI)(NYSE Euronext, FR0011191766 – EOSI), the orthopaedic 2D/3D imaging pioneer, announced its consolidated 2013 half-year results, as approved by the Board of Directors at its meeting on August 28, 2013.

EOS imaging's consolidated revenue over the first half of 2013 was €4.91 million, a 111% increase from the first half of the previous financial year.

Help employers find you! Check out all the jobs and post your resume.